Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.305 HKD | 0.00% | -4.69% | -69.19% |
Mar. 28 | CANbridge Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 08 | CANbridge Pharmaceuticals Grants Share Options, Restricted Shares | MT |
Chart calendar CANbridge Pharmaceuticals Inc.
Upcoming events on CANbridge Pharmaceuticals Inc.
Past events on CANbridge Pharmaceuticals Inc.
2024-03-27 | Q4 2023 Earnings Release |
2023-09-10 | H.C. Wainwright Global Investment Conference |
2023-08-31 03:15 am | Q2 2023 Earnings Release |
2023-08-30 09:30 pm | Q2 2023 Earnings Call |
2023-06-26 09:00 pm | Annual General Meeting |
2023-06-26 | CAN106 Phase 1b Update Call |
2023-06-06 | Jefferies Global Healthcare Conference |
2023-06-06 10:00 am | CAN108 NDA Approval Call |
2023-05-17 03:00 pm | American Society of Gene Cell Therapy Meeting |
2023-03-30 09:00 pm | Q4 2023 Earnings Call |
2023-03-29 | Q4 2022 Earnings Release |
2023-03-19 | European Society of Medical Oncologists (ESMO) Sarcoma and Rare Cancers Congress - Poster No: 2P |
2022-11-15 | Morgan Stanley Flagship Asia Pacific Summit |
2022-11-14 | Jefferies London Healthcare Conference |
2022-10-13 12:00 pm | European Society of Gene & Cell Therapy Congress - Poster No. 0R57 |
2022-10-13 10:30 am | ESGCT Congress |
2022-09-28 11:40 am | Complement Based Drug Development Summit |
2022-09-25 | J.P. Morgan Global Healthcare Shanghai Conference |
2022-09-24 04:05 am | Hematolgoy National Conference |
2022-09-14 04:05 pm | Morgan Stanley Global Healthcare Conference |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 0,00 | 31,2 33,7 -7.63% | 79,0 77,5 1.95% | 103 77,0 33.68% |
EBITDA Million CNY | Released Forecast Spread | 0,00 | -639 -618 -3.43% | -436 -485 10.02% | -354 -409 13.57% |
EBIT Million CNY | Released Forecast Spread | 0,00 | -655 -630 -4.05% | -477 -495 3.69% | -370 -415 10.96% |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 | -1 077 -701 -53.57% | -483 -501 3.48% | -379 -419 9.55% |
Net income Million CNY | Released Forecast Spread | -846 | -1 077 -701 -53.57% | -483 -501 3.48% | -379 -419 9.55% |
EPS HKD | Released Forecast Spread | -15,1 | -14,0 -19,4 27.64% | -1,30 -1,34 3.03% | -0,96 -1,08 10.76% |
Announcement Date | 30/11/21 | 22/03/22 | 30/03/23 | 28/03/24 |
Past sector events for CANbridge Pharmaceuticals Inc.
Today | OSCOTEC INC.: Q4 2023 Earnings Release (Projected) |
Today | SHANDONG JINCHENG PHARMACEUTICAL GROUP CO., LTD: Q4 2023 Earnings Release |
2024-03-27 | SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.: Q4 2023 Earnings Release |
2024-03-22 02:45 am | ECKERT & ZIEGLER SE: Q4 2023 Earnings Release |
2024-03-19 | CHANGCHUN BCHT BIOTECHNOLOGY CO.: Q4 2023 Earnings Release |
2024-03-11 | SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
2024-03-07 01:00 am | MERCK KGAA: Q4 2023 Earnings Release |
2024-02-27 04:05 pm | SUPERNUS PHARMACEUTICALS, INC.: Q4 2023 Earnings Release |
2024-02-22 02:00 am | INDIVIOR PLC: Q4 2023 Earnings Release |
2024-02-21 01:43 am | CALLIDITAS THERAPEUTICS AB: Q4 2023 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock CANbridge Pharmaceuticals Inc. - Hong Kong S.E.
- Calendar CANbridge Pharmaceuticals Inc.